The Indian pharmaceutical market size was valued at USD 48.4 Billion in 2022. When we look ahead, the market is in the growth trajectory phase as it anticipates reaching USD 102.7 Billion by 2028, showcasing a growth rate of 13.01% during 2023-202...
Neonatal care has come a long way in recent years, with advancements in medical technology and innovative approaches transforming the landscape of newborn healthcare. In India, where the rate of preterm births and neonatal mortality has been a lon...
The emerging trends of CDMOs reflect the country's growing prominence as a preferred outsourcing destination for drug development and manufacturing activities The growth and evolution of the CDMO industry have been driven by factors such as cost a...
Beneath the superficial veneer of device usability analysis lies a complex and multi-dimensional paradigm. It necessitates the use of ethnographic methodologies, immersive contextual analysis, and a granular understanding of user behavior, encompa...
Establishing a strong brand identity is critical for success in the intensely competitive pharmaceutical market. A captivating brand identity is more than simply a logo and a tagline; it represents the company's values, goals, and purpose.
The market for prefilled syringes was estimated to be worth USD 7.22 billion in 2022 and is anticipated to grow to USD 7.91 billion in 2023. By 2030, the market is anticipated to reach USD 16.32 billion, growing at a CAGR of 10.9%. Prefilled...
The agreement was launched by AliveCor India Pvt. Ltd., the leading inventor in FDA-cleared personal electrocardiogram (ECG) technology, and Vieroots Wellness Solutions Pvt Ltd, a health-tech start-up focused to giving personalised solutions to...
Zion Pharma Limited, a Chinese biotechnology firm specialising in the creation of substances that may penetrate the brain, revealed today that Roche has purchased the worldwide rights to Zion's principal programme, ZN-A-1041. ZN-A-1041 is a Human...
Technologies are revolutionizing the way veterinarians diagnose and treat diseases in animals. Veterinary medicine embraces these technologies to provide more efficient and cost-effective medical care.
Zydus Lifesciences on Monday said it has received approval from the US health regulator to market a generic medication that is used to lower triglycerides, in the American market.The company has got the final approval from the US Food and Drug A...
, CDSCO.jpg)
